Skip to content

DHCare Belgium

Active
Public limited companyfounded 1996active for 30 yearsAutobaan 22, 8210 Zedelgem, BelgiumKBO/BCE: BE 0458.249.477
Summary

DHCare Belgium has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €224,724. Equity is shrinking by about 6.2% per year across the filed financial years. Its solvency ranks better than 55% of 9,723 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€2.8mtotal assets 2025
Staff
9.4 FTE
Equity
€1.3m
Profit
€224,724
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
Invacare Holdings two BV · 100%
Auditor: Grant Thomton BedrijferevisorenAccounts 35 days early3 of 17 deeds read
Why 93lowers riskFounded in 1996Figures for financial year 2025 (filed 26-05-2026)Profit of €224,724 (financial year 2025)Equity €1.3m (47.7% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 59% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Strong
Solvency 73+1
equity 47.7% of total assets
Liquidity 37-5
short-term debt 48.5% · cash 8.5%
Profitability 79=
return on assets 8.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,862 companies, NACE 46, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025highest value 07-2025: 0.1%▼ -0.1 percentage points vs 06-2025lowest value 08-2025: 0.1%● unchanged vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €120,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.05, compared with 2.03 in 2024, above the usual 1.5; short-term debt: 48.5% and cash: 8.5% of total assets), but 52.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 56% on solvency, 34% on liquidity, 70% on profitability and 76% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskneutral
lowers risk · Founded in 1996
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 26-05-2026)
NBB · annual accounts
lowers risk · Profit of €224,724 (financial year 2025)
NBB · annual accounts
lowers risk · Equity €1.3m (47.7% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.3m
neutral · Latest accounts filed on time
The financial year that closed on 30-11-2025 was due by 30-06-2026 and was filed on 26-05-2026, 35 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
35 days early
2024
7 days early
2023
17 days early
2022
3 days early
2021
1 day early
2020
12 days early
2019
12 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 30-11-2026 and is due by 30-06-2027. Nothing is late today. The company usually files around 23 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
22-10-2026 today30-11-2026 year end30-06-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: S. Vercaemer (director)Appointment: A. R. Hollyhead (director)…
  2. NameName change · Power of…
  3. Annual accounts filedfinancial year 2025 · abbreviated…

Key points

  • Caution: Board changedlatest change 29-06-2026 · 1 in office 1 joined · 1 left View
  • Positive: Among the best 16% on net resultsector median €27,057 · 9,702 companies €224,724 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €224,724 8 years View
  • Controlled by Invacare Holdings two BVultimately: Invacare Holdings C.V. 100% View

By topic

Financials

Financial year
2025
Total assets
€2.8m
Profit
€224,724
Solvency
47.7%
Turnover▼ 7.3%
Net result
20182020
Go to Financials

Board & ownership

Board
1 member
Parent
Invacare Holdings two BV · 100%
Auditor
Grant Thomton Bedrijferevisoren
  • A. R. HollyheadDirector
Go to Board & ownership

Timeline

Events
35
Since
1998
Next accounts
by 30-06-2027
  1. 23-06-2025Annual accounts filed
  2. 30-11-2024Equity above €1m
  3. 10-09-2024Appointment: Grant Thomton Bedrijferevisoren (statutory auditor)
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
24-06-1996
Year ends
30-11
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.